The present invention is directed to: a) a method of treating telangiectasia b) a method of treating inflammatory lesions and c) a method of treating two or more symptoms of rosacea selected from erythema telangiectasia or inflammatory lesions comprising topical administration of a pharmaceutical composition comprising oxymetazoline and a pharmaceutically acceptable excipient.
